PMID: 37337Jun 1, 1979

beta-Adrenergic blocking agents with acute antihypertensive activity

Journal of Medicinal Chemistry
J J BaldwinR Hall


Modification of the pharmacological profile of the vasodilating/beta-adrenergic blocking agent 2-[4-[3-(tert-butylamino)-2-hydroxypropoxy]phenyl]-4-(trifluoromethyl)imidazole (1) has been investigated. Introduction of selected substitutents onto the imidazole ring, in place of the trifluoromethyl group, has yielded highly cardioselective beta-adrenergic blocking agents such as 7, 17, and 18. The placement of alkyl or chloro groups onto the aryl ring of 1, as illustrated by 33, has produced a class of compounds characterized as antihypertensive beta-adrenergic blocking agents. In these examples, the acute antihypertensive activity does not appear to be due to either vasodilating or beta 2-agonist properties.


Feb 8, 1980·European Journal of Pharmacology·D DeitchmanR W Snyder
May 31, 2012·Journal of the American Chemical Society·Adam S DuerfeldtBrian S J Blagg

Related Concepts

Adrenergic beta-Antagonists
Airway Resistance
Antihypertensive Agents
Diastolic Blood Pressure
Canis familiaris
Pulse Rate
Hypertensive Disease
Structure of Iliac Artery

Related Feeds

Antihypertensive Agents: Mechanisms of Action

Antihypertensive drugs are used to treat hypertension (high blood pressure) which aims to prevent the complications of high blood pressure, such as stroke and myocardial infarction. Discover the latest research on antihypertensive drugs and their mechanism of action here.